JP7881477B2 - 間質性肺疾患の治療における使用のためのトレプロスチニル - Google Patents
間質性肺疾患の治療における使用のためのトレプロスチニルInfo
- Publication number
- JP7881477B2 JP7881477B2 JP2022562484A JP2022562484A JP7881477B2 JP 7881477 B2 JP7881477 B2 JP 7881477B2 JP 2022562484 A JP2022562484 A JP 2022562484A JP 2022562484 A JP2022562484 A JP 2022562484A JP 7881477 B2 JP7881477 B2 JP 7881477B2
- Authority
- JP
- Japan
- Prior art keywords
- weeks
- treprostinil
- administration
- substituted
- patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063011810P | 2020-04-17 | 2020-04-17 | |
| US63/011,810 | 2020-04-17 | ||
| US202163160611P | 2021-03-12 | 2021-03-12 | |
| US63/160,611 | 2021-03-12 | ||
| PCT/US2021/027588 WO2021211916A1 (en) | 2020-04-17 | 2021-04-16 | Treprostinil for use in the treatment of intersitial lung disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023523557A JP2023523557A (ja) | 2023-06-06 |
| JP2023523557A5 JP2023523557A5 (cg-RX-API-DMAC7.html) | 2024-04-25 |
| JP7881477B2 true JP7881477B2 (ja) | 2026-06-29 |
Family
ID=75870729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562484A Active JP7881477B2 (ja) | 2020-04-17 | 2021-04-16 | 間質性肺疾患の治療における使用のためのトレプロスチニル |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US11826327B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4135707A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7881477B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230011929A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115916212A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2021255621B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3172665A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL296567A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021211916A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL296567A (en) * | 2020-04-17 | 2022-11-01 | United Therapeutics Corp | Terfostinil for use in the treatment of interstitial lung disease |
| WO2022187352A1 (en) * | 2021-03-03 | 2022-09-09 | United Therapeutics Corporation | A dry powder composition of trestinil and its prodrug thereof and further comprising comprising (e)-3,6-bis[4-(n-carbonyl-2-propenyl)amidobutyl]-2,5-diketopiperazine (fdkp) |
| CA3235985A1 (en) * | 2021-10-27 | 2023-05-04 | Mannkind Corporation | Methods and compositions for treating pulmonary hypertension |
| WO2023154705A1 (en) | 2022-02-08 | 2023-08-17 | United Therapeutics Corporation | Treprostinil iloprost combination therapy |
| CN121241041A (zh) * | 2023-01-19 | 2025-12-30 | 联合治疗公司 | 曲前列尼尔类似物及相关制备和使用方法 |
| WO2026064480A1 (en) * | 2024-09-18 | 2026-03-26 | Mannkind Corporation | Method and composition for treating lung diseases |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010518122A (ja) | 2007-02-09 | 2010-05-27 | ユナイテッド セラピューティクス コーポレーション | 間質性肺疾患および喘息のためのトレプロスチニル処置 |
| JP2019112434A (ja) | 2006-05-15 | 2019-07-11 | ユナイテッド セラピューティクス コーポレイション | 定量吸入器を用いたトレプロスチニル投与 |
| WO2019237028A1 (en) | 2018-06-07 | 2019-12-12 | Mannkind Corporation | Composition and method for inhalation |
Family Cites Families (131)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3664337A (en) | 1970-04-15 | 1972-05-23 | Bio Logics Inc | Respiration assembly and methods |
| US4001650A (en) | 1975-09-02 | 1977-01-04 | Puritan-Bennett Corporation | Method and apparatus for ultrasonic transducer protection |
| US4007238A (en) | 1976-02-25 | 1977-02-08 | Glenn Joseph G | Nebulizer for use with IPPB equipment |
| US4473296A (en) | 1978-05-03 | 1984-09-25 | Ppm, Inc. | System and method and apparatus for a continuous aerosol monitor (CAM) using electro-optical weighing for general aerosols |
| DE2845770A1 (de) | 1978-10-19 | 1980-04-30 | Schering Ag | Neue prostacyclin-derivate und verfahren zu ihrer herstellung |
| US4281113A (en) | 1979-07-31 | 1981-07-28 | The Upjohn Company | 2,5-Inter-o-phenylene-3,4-dinor-6,9α-epoxy-6.beta.-5-iodo-PGF1 compounds |
| US4306075A (en) | 1980-03-28 | 1981-12-15 | The Upjohn Company | Composition and process |
| US4306076A (en) | 1980-04-23 | 1981-12-15 | The Upjohn Company | Inter-phenylene CBA compounds |
| DE3048906A1 (de) | 1980-12-19 | 1982-07-15 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US4349689A (en) | 1980-12-22 | 1982-09-14 | The Upjohn Company | Methano carbacyclin analogs |
| US4486598A (en) | 1982-02-22 | 1984-12-04 | The Upjohn Company | Carbacyclin analogs |
| US4495944A (en) | 1983-02-07 | 1985-01-29 | Trutek Research, Inc. | Inhalation therapy apparatus |
| US4683330A (en) | 1984-03-08 | 1987-07-28 | The Upjohn Company | Interphenylene carbacyclin derivatives |
| US4668814A (en) | 1984-03-08 | 1987-05-26 | The Upjohn Company | Interphenylene carbacyclin derivatives |
| US4635647A (en) | 1984-09-07 | 1987-01-13 | Choksi Pradip V | Incentive spirometer employing bellows air flow sensor |
| NZ209900A (en) | 1984-10-16 | 1989-08-29 | Univ Auckland | Automatic inhaler |
| US4976259A (en) | 1986-12-22 | 1990-12-11 | Mountain Medical Equipment, Inc. | Ultrasonic nebulizer |
| US5080093A (en) | 1987-07-08 | 1992-01-14 | Vortran Medical Technology, Inc. | Intermittant signal actuated nebulizer |
| US5322057A (en) | 1987-07-08 | 1994-06-21 | Vortran Medical Technology, Inc. | Intermittent signal actuated nebulizer synchronized to operate in the exhalation phase, and its method of use |
| FI82808C (fi) | 1987-12-31 | 1991-04-25 | Etelae Haemeen Keuhkovammayhdi | Ultraljudfinfoerdelningsanordning. |
| GB8814438D0 (en) | 1988-06-17 | 1988-07-20 | Wellcome Found | Compounds for use in medicine |
| US4984158A (en) | 1988-10-14 | 1991-01-08 | Hillsman Dean | Metered dose inhaler biofeedback training and evaluation system |
| GB9011588D0 (en) | 1990-05-24 | 1990-07-11 | Wellcome Found | Prostaglandin analogues for use in medicine |
| ES2141108T3 (es) | 1991-07-02 | 2000-03-16 | Inhale Inc | Metodo y dispositivo para proporcionar medicamentos en aerosol. |
| GB2265845B (en) | 1991-11-12 | 1996-05-01 | Medix Ltd | A nebuliser and nebuliser control system |
| US5363842A (en) | 1991-12-20 | 1994-11-15 | Circadian, Inc. | Intelligent inhaler providing feedback to both patient and medical professional |
| FR2694215B1 (fr) | 1992-07-30 | 1994-10-21 | Dp Medical | Appareil pour générer un brouillard à partir d'un liquide, notamment un médicament. |
| CA2146870C (en) | 1992-10-16 | 2005-04-12 | Vladimir Cheiman | Ultrasonic nebulising device |
| US5497763A (en) | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| US5752502A (en) | 1993-12-16 | 1998-05-19 | King; Russell Wayne | General purpose aerosol inhalation apparatus |
| US5881715A (en) | 1995-07-10 | 1999-03-16 | A & D Company, Limited | Handy type atomizer |
| FR2746656B1 (fr) | 1996-03-26 | 1999-05-28 | System Assistance Medical | Nebuliseur a capteur de pression |
| US6441245B1 (en) | 1997-10-24 | 2002-08-27 | United Therapeutics Corporation | Process for stereoselective synthesis of prostacyclin derivatives |
| ES2214753T3 (es) | 1997-11-14 | 2004-09-16 | United Therapeutics Corporation | Uso de 9-desoxi-2',9-alfa-metano-3-oxa-4,5,6-trinor-3,7-(1',3'-interfenilen)-13,14-dihidro-prostaglandina f1 para tratar la enfermedad vascular periferica. |
| DE19838711C1 (de) | 1998-08-26 | 2000-06-21 | Otto Schill Gmbh & Co Kg | Inhalator zum Vernebeln von Flüssigkeiten |
| FR2783431B1 (fr) | 1998-09-23 | 2001-02-02 | System Assistance Medical | Nebuliseur permettant de delivrer un brouillard a un patient et procede de fonctionnement d'un tel nebuliseur |
| SE9900369D0 (sv) | 1999-02-04 | 1999-02-04 | Siemens Elema Ab | Ultrasonic nebuliser |
| US6521212B1 (en) | 1999-03-18 | 2003-02-18 | United Therapeutics Corporation | Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation |
| KR20020012169A (ko) | 1999-03-31 | 2002-02-15 | 유나이티드 쎄러퓨틱스 코포레이션 | 프로스타글란딘 화합물, 조성물 및 말초혈관질병 및폐고혈압증의 치료방법 |
| DE19934582C2 (de) | 1999-07-23 | 2003-09-18 | Otto Schill Gmbh & Co Kg | Aerosolerzeuger |
| CA2635489A1 (en) | 2000-02-11 | 2001-08-16 | Respironics Respiratory Drug Delivery (Uk) Ltd | Drug delivery apparatus |
| DE10022795B4 (de) | 2000-05-10 | 2005-04-14 | Pari GmbH Spezialisten für effektive Inhalation | Atemgesteuertes Inhalationstherapiegerät |
| US6242482B1 (en) | 2000-06-05 | 2001-06-05 | United Therapeutics Corporation | Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure |
| JP2004512101A (ja) | 2000-10-20 | 2004-04-22 | グラクソ グループ リミテッド | 吸入器 |
| US6700025B2 (en) | 2001-01-05 | 2004-03-02 | United Therapeutics Corporation | Process for stereoselective synthesis of prostacyclin derivatives |
| WO2003026556A2 (en) | 2001-09-12 | 2003-04-03 | Ivax Corporation | Breath-enhanced ultrasonic nebulizer and dedicated unit dose ampoule |
| US6626843B2 (en) | 2001-09-28 | 2003-09-30 | Deane Hillsman | Respiratory timing and lung deflation method and device |
| US6803386B2 (en) | 2002-01-16 | 2004-10-12 | United Therapeutics Corporation | Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer |
| US20040063912A1 (en) | 2002-03-15 | 2004-04-01 | The Brigham And Women's Hospital, Inc. | Central airway administration for systemic delivery of therapeutics |
| US20030192532A1 (en) | 2002-04-12 | 2003-10-16 | Hopkins Andrew David | Nebulizer |
| US7550133B2 (en) | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
| JP2006507905A (ja) | 2002-12-02 | 2006-03-09 | スコット・ラボラトリーズ・インコーポレイテッド | 呼吸監視システムおよび方法 |
| US6756117B1 (en) | 2002-12-20 | 2004-06-29 | The United States Of America As Represented By The United States Department Of Energy | Photonic polymer-blend structures and method for making |
| US7726303B2 (en) | 2003-02-25 | 2010-06-01 | Hewlett-Packard Development Company, L.P. | Controlled medicament ejection |
| CN102697790A (zh) | 2003-05-22 | 2012-10-03 | 联合治疗公司 | 化合物和释放前列环素类似物的方法 |
| US20040265238A1 (en) | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
| JP4357230B2 (ja) | 2003-07-14 | 2009-11-04 | 帝人株式会社 | 酸素濃縮装置、在宅酸素療法システム |
| US7172557B1 (en) | 2003-08-29 | 2007-02-06 | Caldyne, Inc. | Spirometer, display and method |
| JP2005120069A (ja) | 2003-10-13 | 2005-05-12 | Anges Mg Inc | 炎症性疾患治療薬 |
| US7199157B2 (en) | 2003-12-16 | 2007-04-03 | United Therapeutics Corporation | Use of treprostinil to improve kidney functions |
| US20090124697A1 (en) | 2003-12-16 | 2009-05-14 | United Therapeutics Corporation | Inhalation formulations of treprostinil |
| CN1917866B (zh) | 2003-12-16 | 2010-12-15 | 联合治疗公司 | 曲前列环素或它的衍生物,或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途 |
| US7380550B2 (en) | 2004-01-30 | 2008-06-03 | Hewlett-Packard Development Company, L.P. | Systems and methods for particle detection |
| DE102004009436A1 (de) | 2004-02-24 | 2005-10-13 | Boehringer Ingelheim International Gmbh | Zerstäuber |
| DE602005020269D1 (de) | 2004-04-12 | 2010-05-12 | United Therapeutics Corp | Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren |
| CA2574958A1 (en) | 2004-07-26 | 2006-02-09 | Cotherix, Inc. | Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation |
| US7721729B2 (en) | 2005-03-09 | 2010-05-25 | Ric Investments, Llc | Nebulizing drug delivery device for ventilator |
| US8747897B2 (en) | 2006-04-27 | 2014-06-10 | Supernus Pharmaceuticals, Inc. | Osmotic drug delivery system |
| DE102006026786A1 (de) | 2006-06-07 | 2007-12-13 | Joachim Kern | Dosierinhalator |
| US20090036465A1 (en) | 2006-10-18 | 2009-02-05 | United Therapeutics Corporation | Combination therapy for pulmonary arterial hypertension |
| WO2008088727A2 (en) | 2007-01-12 | 2008-07-24 | Concert Pharmaceuticals, Inc. | Endothelin receptor antagonists |
| CN103181893A (zh) | 2007-09-07 | 2013-07-03 | 联合治疗公司 | 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法 |
| WO2009078965A1 (en) | 2007-12-17 | 2009-06-25 | United Therapeutics Corporation | An improved process to prepare treprostinil, the active ingredient in remodulin |
| JP6219016B2 (ja) | 2008-05-08 | 2017-10-25 | ユナイテッド セラピューティクス コーポレーション | トレプロスチニル一水和物 |
| EP2330893A4 (en) | 2008-09-25 | 2013-01-09 | Aradigm Corp | DEEP PULMONARY ADMINISTRATION OF TREPROSTINIL |
| CN102421288B (zh) | 2009-05-07 | 2015-04-22 | 联合治疗公司 | 前列环素类似物的固体剂型 |
| AU2010280684B2 (en) | 2009-08-07 | 2016-07-28 | Scipharm Sarl | Composition for the treatment of cystic fibrosis |
| KR20160132501A (ko) | 2010-03-15 | 2016-11-18 | 유나이티드 세러퓨틱스 코오포레이션 | 폐고혈압의 치료 |
| CN103261142B (zh) | 2010-06-03 | 2014-12-10 | 联合治疗公司 | 曲前列环素的制备 |
| WO2012009097A1 (en) * | 2010-06-17 | 2012-01-19 | Cytokinetics, Inc. | Methods of treating lung disease |
| CA2710726C (en) | 2010-07-22 | 2016-02-23 | Alphora Research Inc. | Synthesis of treprostinil and intermediates useful therein |
| CA2710725C (en) | 2010-07-22 | 2017-08-01 | Alphora Research Inc. | Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation |
| CA2726599C (en) | 2010-12-30 | 2017-07-25 | Alphora Research Inc. | Process for treprostinil salt preparation |
| ES2581762T3 (es) | 2011-03-02 | 2016-09-07 | United Therapeutics Corporation | Síntesis de producto intermedio para la producción de treprostinil |
| US9388154B2 (en) | 2011-09-12 | 2016-07-12 | Lund Biotechnology PBC | Process for preparing synthetic prostacyclins |
| CN103193626B (zh) | 2012-01-10 | 2016-05-11 | 上海天伟生物制药有限公司 | 一种前列腺素类似物的晶型及其制备方法和用途 |
| CN103193627B (zh) | 2012-01-10 | 2016-04-20 | 上海天伟生物制药有限公司 | 一种前列腺素类似物的晶型及其制备方法和用途 |
| US9387214B2 (en) | 2012-01-13 | 2016-07-12 | United Therapeutics Corporation | Method of identifying therapies for pulmonary hypertension |
| EA037448B1 (ru) | 2012-06-08 | 2021-03-30 | Этрис Гмбх | Способ доставки в легкие терапевтической мрнк с pei и фармацевтическая композиция |
| SI2674413T1 (sl) | 2012-06-15 | 2017-10-30 | Scipharm Sarl | Postopek za pripravo treprostinila in derivatov le-tega |
| WO2014085813A1 (en) | 2012-11-30 | 2014-06-05 | Insmed Incorporated | Prostacylin compositions and methods for using the same |
| CN104837806A (zh) | 2012-12-07 | 2015-08-12 | 开曼化学股份有限公司 | 前列环素类似物的合成方法 |
| EP3712142B1 (en) | 2013-01-11 | 2022-07-06 | Corsair Pharma, Inc. | Prodrugs of treprostinil |
| US9505737B2 (en) | 2013-01-11 | 2016-11-29 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
| US20140271923A1 (en) | 2013-03-14 | 2014-09-18 | Christopher Brian Reid | Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions |
| WO2014159050A1 (en) | 2013-03-14 | 2014-10-02 | United Therapeutics Corporation | Solid forms of treprostinil |
| EP2970081A4 (en) | 2013-03-15 | 2016-10-12 | United Therapeutics Corp | SALTS OF TREPROSTINIL |
| CA2911172C (en) | 2013-04-30 | 2021-10-19 | United Therapeutics Corporation | Controlled release pharmaceutical formulations |
| US9469600B2 (en) | 2013-10-25 | 2016-10-18 | Insmed Incorporated | Prostacyclin compounds, compositions and methods of use thereof |
| JP2016538161A (ja) | 2013-11-27 | 2016-12-08 | コーニング インコーポレイテッド | 基板の改善された製造のための組成 |
| WO2015138423A1 (en) * | 2014-03-11 | 2015-09-17 | Insmed Incorporated | Prostacylin compositions and methods for using the same |
| TWI685348B (zh) | 2014-05-08 | 2020-02-21 | 美國禮來大藥廠 | 速效胰島素組合物 |
| ES2908142T3 (es) | 2014-06-13 | 2022-04-27 | United Therapeutics Corp | Formulaciones de treprostinil |
| US20160045470A1 (en) | 2014-08-12 | 2016-02-18 | Dr. Reddy's Laboratories Limited | Amorphous solid dispersion of treprostinil diethanolamine |
| WO2016038532A1 (en) | 2014-09-09 | 2016-03-17 | Mylan Laboratories Limited | Amorphous treprostinil diethanolamine |
| HU231184B1 (hu) | 2014-10-08 | 2021-07-28 | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. | Treprostinil-nátrium-monohidrát és eljárás ennek előállítására |
| CN107108427A (zh) | 2014-10-20 | 2017-08-29 | 联合治疗学有限公司 | 用于制备前列环素衍生物的中间体的合成 |
| US10343979B2 (en) | 2014-11-18 | 2019-07-09 | Insmed Incorporated | Methods of manufacturing treprostinil and treprostinil derivative prodrugs |
| TWI540121B (zh) | 2014-12-01 | 2016-07-01 | 臺灣永光化學工業股份有限公司 | 曲前列環素二乙醇胺之合成方法及新穎中間體 |
| WO2016105538A1 (en) | 2014-12-23 | 2016-06-30 | Sandia Corporation Sandia National Laboratories | Adjusting the ph of a pretreatment solution using carbon dioxide useful for integrating saccharification and fermentation |
| US20180110774A1 (en) | 2015-04-28 | 2018-04-26 | Stc. Unm | Compositions and methods for treatment of pulmonary hypertension |
| US9643911B2 (en) | 2015-06-17 | 2017-05-09 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| US9394227B1 (en) | 2015-06-17 | 2016-07-19 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| US20190321290A1 (en) | 2016-01-29 | 2019-10-24 | Mannkind Corporation | Composition and method for inhalation |
| MX421795B (es) | 2016-03-18 | 2025-03-14 | Christopher Brian Reid | Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades |
| KR20180133401A (ko) | 2016-04-08 | 2018-12-14 | 이데미쓰 고산 가부시키가이샤 | 전기 화학 소자용 바인더 |
| EP3452170A4 (en) | 2016-05-05 | 2020-04-01 | Liquidia Technologies, Inc. | TREPROSTINIL IN POWDER FORM FOR TREATING PULMONAL HYPERTENSION |
| AU2017296040C1 (en) | 2016-07-15 | 2023-06-22 | Acceleron Pharma Inc. | Compositions and methods for treating pulmonary hypertension |
| WO2018058124A1 (en) | 2016-09-26 | 2018-03-29 | United Therapeutics Corporation | Treprostinil prodrugs |
| CN110381930A (zh) | 2016-12-05 | 2019-10-25 | 康赛制药公司 | 曲前列环素及其盐的经皮和透皮施用 |
| EP3554507A1 (en) | 2016-12-14 | 2019-10-23 | Respira Therapeutics, Inc. | Methods and compositions for treatment of pulmonary hypertension and other lung disorders |
| JP6893012B2 (ja) | 2017-07-18 | 2021-06-23 | 徳義制薬有限公司Deyi Pharmarmaceutical Ltd. | 肺高血圧症の治療におけるカンナビジオールの応用 |
| CN109260182B (zh) | 2017-07-18 | 2021-06-29 | 德义制药有限公司 | 大麻二酚在制备治疗肺动脉高压药物中的应用 |
| US20210038510A1 (en) | 2018-02-08 | 2021-02-11 | Pulmokine, Inc. | Formulations of kinase inhibitors and prostanoids |
| SG11202011045VA (en) | 2018-05-07 | 2020-12-30 | Pharmosa Biopharm Inc | Pharmaceutical composition for controlled release of treprostinil |
| US20210205253A1 (en) | 2018-05-31 | 2021-07-08 | The Asan Foundation | Use Of Stearic Acid For Preventing Or Treating Pulmonary Fibrosis |
| US20200085741A1 (en) | 2018-09-14 | 2020-03-19 | Pharmosa Biopharm Inc. | Pharmaceutical composition for controlled release of weak acid drugs and uses thereof |
| CN109734580A (zh) | 2019-03-05 | 2019-05-10 | 江苏众强药业有限公司 | 曲前列尼尔钠盐新晶型及制备方法 |
| CN114616225A (zh) | 2019-08-23 | 2022-06-10 | 联合治疗公司 | 曲前列环素前药 |
| CN110585205A (zh) | 2019-09-17 | 2019-12-20 | 中国人民解放军总医院 | Wnk激酶抑制剂在预防和/或治疗肺动脉高压中的用途 |
| IL296567A (en) * | 2020-04-17 | 2022-11-01 | United Therapeutics Corp | Terfostinil for use in the treatment of interstitial lung disease |
-
2021
- 2021-04-16 IL IL296567A patent/IL296567A/en unknown
- 2021-04-16 KR KR1020227038281A patent/KR20230011929A/ko active Pending
- 2021-04-16 JP JP2022562484A patent/JP7881477B2/ja active Active
- 2021-04-16 US US17/233,061 patent/US11826327B2/en active Active
- 2021-04-16 CN CN202180042410.0A patent/CN115916212A/zh active Pending
- 2021-04-16 AU AU2021255621A patent/AU2021255621B2/en active Active
- 2021-04-16 EP EP21724428.4A patent/EP4135707A1/en active Pending
- 2021-04-16 WO PCT/US2021/027588 patent/WO2021211916A1/en not_active Ceased
- 2021-04-16 CA CA3172665A patent/CA3172665A1/en active Pending
-
2024
- 2024-02-23 US US18/586,056 patent/US20250049742A1/en active Pending
-
2025
- 2025-11-25 US US19/400,227 patent/US20260076929A1/en active Pending
- 2025-11-25 US US19/400,211 patent/US20260076928A1/en active Pending
- 2025-12-15 US US19/420,084 patent/US12697315B2/en active Active
-
2026
- 2026-07-20 AU AU2026206249A patent/AU2026206249A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019112434A (ja) | 2006-05-15 | 2019-07-11 | ユナイテッド セラピューティクス コーポレイション | 定量吸入器を用いたトレプロスチニル投与 |
| JP2010518122A (ja) | 2007-02-09 | 2010-05-27 | ユナイテッド セラピューティクス コーポレーション | 間質性肺疾患および喘息のためのトレプロスチニル処置 |
| WO2019237028A1 (en) | 2018-06-07 | 2019-12-12 | Mannkind Corporation | Composition and method for inhalation |
Non-Patent Citations (1)
| Title |
|---|
| Lung,2018年,Vol.196,pp.139-146 |
Also Published As
| Publication number | Publication date |
|---|---|
| US12697315B2 (en) | 2026-08-04 |
| AU2021255621B2 (en) | 2026-07-23 |
| AU2026206249A1 (en) | 2026-08-06 |
| CN115916212A (zh) | 2023-04-04 |
| WO2021211916A1 (en) | 2021-10-21 |
| US20260076928A1 (en) | 2026-03-19 |
| KR20230011929A (ko) | 2023-01-25 |
| US20260102366A1 (en) | 2026-04-16 |
| AU2021255621A1 (en) | 2022-10-20 |
| JP2023523557A (ja) | 2023-06-06 |
| US20250049742A1 (en) | 2025-02-13 |
| EP4135707A1 (en) | 2023-02-22 |
| US20210330621A1 (en) | 2021-10-28 |
| CA3172665A1 (en) | 2021-10-21 |
| US20260076929A1 (en) | 2026-03-19 |
| IL296567A (en) | 2022-11-01 |
| US11826327B2 (en) | 2023-11-28 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221215 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240415 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240415 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250318 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250325 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250624 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250924 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251007 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260106 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260406 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260406 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260519 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260617 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7881477 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |